This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Institute of Oriental Medicine. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Jin-Mu Yi in Peripheral Neuropathy Treatment
Introduction
Jin-Mu Yi is an accomplished inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of peripheral neuropathy. His innovative work focuses on utilizing natural extracts to alleviate the side effects of cancer treatments.
Latest Patents
Jin-Mu Yi holds a patent for a composition aimed at the prevention, alleviation, or treatment of peripheral neuropathy. This composition comprises Lithospermi Radix extract as an effective component. The patent highlights the extract's ability to prevent, alleviate, or treat peripheral neuropathy, especially that induced by anti-cancer agents such as chemotherapy. The method involves administering the composition to individuals in need, showcasing its potential to relieve the suppressed growth of neurites without inducing cytotoxicity in normal cells. Furthermore, the extract can effectively lower the heightened sensitivity to painful stimuli in peripheral neuropathic animals caused by chemotherapy.
Career Highlights
Jin-Mu Yi is affiliated with the Korea Institute of Oriental Medicine, where he conducts research and develops innovative solutions for health challenges. His work is characterized by a commitment to improving patient outcomes through natural remedies.
Collaborations
Jin-Mu Yi collaborates with notable colleagues, including No Soo Kim and Jong-Shik Park, to advance research in his field. Their combined expertise contributes to the development of effective treatments for peripheral neuropathy.
Conclusion
Jin-Mu Yi's innovative approach to treating chemotherapy-induced peripheral neuropathy through the use of Lithospermi Radix extract represents a significant advancement in medical research. His contributions are paving the way for more effective and safer treatment options for patients suffering from the side effects of cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
